Gene Name,HGNC ID,MONDO Disease Name,MONDO ID,MOI,Report? ,ClinGen Comments,Internal Comments,,Danielle's Notes:,
ACTA2,HGNC:130,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Yes,,,,,Missing from Disease Naming sheet but displayed on the website and not an Actionability synonym
ACTC1,HGNC:143,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,Pending,Has a Yes? or No? in the Disease Naming sheet
ACTC1,HGNC:143,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,Note: MOI added if available as part of a curation on the website,
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
ACTC1,HGNC:143,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
ACVRL1,HGNC:175,"telangiectasia, hereditary hemorrhagic, type 2",MONDO:0010880,AD,Yes,,,,,
APC,HGNC:583,classic or attenuated familial adenomatous polyposis,MONDO:0021057,AD,Yes,,,,,
APC,HGNC:583,familial adenomatous polyposis 1,MONDO:0021056,,Yes,,,,,
APC,HGNC:583,gastric adenocarcinoma and proximal polyposis of the stomach,MONDO:0017790,AD,Pending,,This disease is caused by promoter variants and actionability has not been evaluated. Also these variants would only be detectable by GS not ES.,,,
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,SD,No,"Missense variants in the LDL-receptor binding domain of apoB impair binding of LDL to the LDL receptor, causing hypercholesterolemia and premature coronary artery disease, the primary features of FH. In contrast, variants resulting in reduced secretion of APOB (mainly nonsense and frameshift variants) cause familial hypobetalipoproteinemia, which is characterized by hypocholesterolemia and resistance to atherosclerosis.",,,,
APOB,HGNC:603,"hypercholesterolemia, autosomal dominant, type B",MONDO:0007751,AD,Yes,"Missense variants in the LDL-receptor binding domain of apoB impair binding of LDL to the LDL receptor, causing hypercholesterolemia and premature coronary artery disease, the primary features of FH. In contrast, variants resulting in reduced secretion of APOB (mainly nonsense and frameshift variants) cause familial hypobetalipoproteinemia, which is characterized by hypocholesterolemia and resistance to atherosclerosis.",,,,
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,AR,Yes,,,,,
BAG3,HGNC:939,myofibrillar myopathy,MONDO:0018943,AD,Yes,,,,,
BAG3,HGNC:939,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
BAG3,HGNC:939,dilated cardiomyopathy 1HH,MONDO:0013479,,Yes,,,,,
BMPR1A,HGNC:1076,pulmonary arterial hypertension,MONDO:0015924,Other,NA,,,,,
BMPR1A,HGNC:1076,juvenile polyposis syndrome,MONDO:0017380,AD,Yes,,,,,
BRCA1,HGNC:1100,"breast-ovarian cancer, familial, susceptibility to, 1",MONDO:0011450,AD,Yes,,,,,
BRCA1,HGNC:1100,"Fanconi anemia, complementation group S",MONDO:0054748,AR,No,,,,,
BRCA2,HGNC:1101,"breast-ovarian cancer, familial, susceptibility to, 2",MONDO:0012933,AD,Yes,,,,,
BRCA2,HGNC:1101,Fanconi anemia complementation group D1,MONDO:0011584,AR,No,,,,,
BTD,HGNC:1122,biotinidase deficiency,MONDO:0009665,AR,Yes,,,,,
BTD,HGNC:1122,Leigh syndrome,MONDO:0009723,AR,NA,,,,,
CACNA1S,HGNC:1397,"malignant hyperthermia, susceptibility to, 5",MONDO:0011163,AD,Yes,,,,,
CACNA1S,HGNC:1397,malignant hyperthermia of anesthesia,MONDO:0018493,,Yes,,,,,
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,AD,Yes,,,,,
CALM1,HGNC:1442,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,Pending,,,,,
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,AD,Yes,,,,,
CALM2,HGNC:1445,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,Pending,,,,,
CALM3,HGNC:1449,long QT syndrome,MONDO:0002442,AD,Yes,,,,,
CALM3,HGNC:1449,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,Pending,,,,,
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia 2,MONDO:0012762,AR,Yes,,,,,
CASQ2,HGNC:1513,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,,,,,
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AR,Yes,,,,,
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,AD,Yes,,,,,
COL3A1,HGNC:2201,"autosomal dominant Ehlers-Danlos syndrome, vascular type",MONDO:0007524,,Yes,,,,,
DES,HGNC:2770,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,Yes,,,,,
DES,HGNC:2770,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
DES,HGNC:2770,myofibrillar myopathy 1,MONDO:0011076,,Yes,,,,,
DSC2,HGNC:3036,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,AD,Yes,,,,,
DSC2,HGNC:3036,arrhythmogenic right ventricular dysplasia 11,MONDO:0012506,,Yes,,,,,
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,Yes,,,,,
DSG2,HGNC:3049,arrhythmogenic right ventricular dysplasia 10,MONDO:0012434,,Yes,,,,,
DSG2,HGNC:3049,dilated cardiomyopathy,MONDO:0005021,AD,NA,,,,,
DSP,HGNC:3052,arrhythmogenic cardiomyopathy with wooly hair and keratoderma,MONDO:0011581,AD,Yes,,,,,
DSP,HGNC:3052,dilated cardiomyopathy,MONDO:0005021,,Yes,,,,,
DSP,HGNC:3052,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,,,,,
ENG,HGNC:3349,"telangiectasia, hereditary hemorrhagic, type 1",MONDO:0008535,AD,Yes,,,,,
ENG,HGNC:3349,juvenile polyposis syndrome,MONDO:0017380,AD,NA,,,,,
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,AD,Yes,,,,,
FBN1,HGNC:3603,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Pending,,,,,
FBN1,HGNC:3603,Shprintzen-Goldberg syndrome,MONDO:0008426,AD,NA,,,,,
FLNC,HGNC:3756,myofibrillar myopathy 5,MONDO:0012289,AD,Yes,,,,,
FLNC,HGNC:3756,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,AD,Yes,,,,,
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,AR,Yes,,,,,
GLA,HGNC:4296,Fabry disease,MONDO:0010526,XL,Yes,,,,,
HFE,HGNC:4886,hemochromatosis type 1,MONDO:0021001,AR,Yes,Report p.C282Y homozygotes only,,,,
HFE,HGNC:4886,hereditary hemochromatosis,MONDO:0006507,,Yes,Report p.C282Y homozygotes only,,,,
HNF1A,HGNC:11621,monogenic diabetes,MONDO:0015967,AD,Yes,,,,,
HNF1A,HGNC:11621,maturity-onset diabetes of the young type 3,MONDO:0010894,,Yes,,,,,
HNF1A,HGNC:11621,maturity-onset diabetes of the young type 2,MONDO:0007453,,NA,,I don't see this one in ClinGen's curations. MODY2 is due to a different gene,,,
KCNH2,HGNC:6251,Brugada syndrome,MONDO:0015263,AD,NA,,,,,
KCNH2,HGNC:6251,long QT syndrome,MONDO:0002442,AD,Yes,,,,,
KCNH2,HGNC:6251,short QT syndrome,MONDO:0000453,AD,Pending,,,,,
KCNH2,HGNC:6251,long QT syndrome 2,MONDO:0013367,,Yes,,,,,
KCNQ1,HGNC:6294,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,,,,,
KCNQ1,HGNC:6294,Jervell and Lange-Nielsen syndrome,MONDO:0002441,AR,No,,,,,
KCNQ1,HGNC:6294,long QT syndrome,MONDO:0002442,AD,Yes,,,,,
KCNQ1,HGNC:6294,short QT syndrome,MONDO:0000453,AD,Pending,,,,,
KCNQ1,HGNC:6294,long QT syndrome 1,MONDO:0100316,,Yes,,,,,
LDLR,HGNC:6547,"hypercholesterolemia, familial, 1",MONDO:0007750,SD,Yes,,,,,
LMNA,HGNC:6636,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,"P/LP LMNA variants that have any case level phenotype evidence of association with cardiac disease (eg, DCM, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and/or arrhythmia) should be reported, whereas previously reported P/LP missense variants never associated with cardiac disease should not be reported. Also, for novel pLOF variants that reach LP without case observations, these variants should be reported given the general association of pLOF LMNA variants with cardiac disease and the evidence summary should include mention of the spectrum of phenotypes that may be observed with LMNA pLOF variation.",,,,
LMNA,HGNC:6636,dilated cardiomyopathy,MONDO:0005021,AD,Yes,"P/LP LMNA variants that have any case level phenotype evidence of association with cardiac disease (eg, DCM, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and/or arrhythmia) should be reported, whereas previously reported P/LP missense variants never associated with cardiac disease should not be reported. Also, for novel pLOF variants that reach LP without case observations, these variants should be reported given the general association of pLOF LMNA variants with cardiac disease and the evidence summary should include mention of the spectrum of phenotypes that may be observed with LMNA pLOF variation.",,,,
LMNA,HGNC:6636,dilated cardiomyopathy 1A,MONDO:0007269,,Yes,"P/LP LMNA variants that have any case level phenotype evidence of association with cardiac disease (eg, DCM, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and/or arrhythmia) should be reported, whereas previously reported P/LP missense variants never associated with cardiac disease should not be reported. Also, for novel pLOF variants that reach LP without case observations, these variants should be reported given the general association of pLOF LMNA variants with cardiac disease and the evidence summary should include mention of the spectrum of phenotypes that may be observed with LMNA pLOF variation.",,,,
LMNA,HGNC:6636,Emery-Dreifuss muscular dystrophy,MONDO:0016830,,Pending,"P/LP LMNA variants that have any case level phenotype evidence of association with cardiac disease (eg, DCM, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and/or arrhythmia) should be reported, whereas previously reported P/LP missense variants never associated with cardiac disease should not be reported. Also, for novel pLOF variants that reach LP without case observations, these variants should be reported given the general association of pLOF LMNA variants with cardiac disease and the evidence summary should include mention of the spectrum of phenotypes that may be observed with LMNA pLOF variation.",,,,
MAX,HGNC:6913,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
MAX,HGNC:6913,pheochromocytoma,MONDO:0008233,,Yes,,,,,
MEN1,HGNC:7010,multiple endocrine neoplasia type 1,MONDO:0007540,AD,Yes,,,,,
MLH1,HGNC:7127,mismatch repair cancer syndrome 1,MONDO:0010159,AR,No,,,,,
MLH1,HGNC:7127,Lynch syndrome,MONDO:0005835,AD,Yes,,,,,
MLH1,HGNC:7127,hereditary breast carcinoma,MONDO:0016419,AD,NA,,,,,
MLH1,HGNC:7127,Lynch syndrome 2,MONDO:0012249,,Yes,,,,,
MLH1,HGNC:7127,mismatch repair cancer syndrome,MONDO:0031219,,No,,,,,
MSH2,HGNC:7325,mismatch repair cancer syndrome 1,MONDO:0010159,AR,No,,,,,
MSH2,HGNC:7325,Lynch syndrome,MONDO:0005835,AD,Yes,,,,,
MSH2,HGNC:7325,hereditary breast carcinoma,MONDO:0016419,AD,NA,,,,,
MSH2,HGNC:7325,mismatch repair cancer syndrome,MONDO:0031219,,No,,,,,
MSH6,HGNC:7329,mismatch repair cancer syndrome 1,MONDO:0010159,AR,No,,,,,
MSH6,HGNC:7329,Lynch syndrome,MONDO:0005835,AD,Yes,,,,,
MSH6,HGNC:7329,hereditary breast carcinoma,MONDO:0016419,AD,NA,,,,,
MSH6,HGNC:7329,Lynch syndrome 5,MONDO:0013710,,Yes,,,,,
MSH6,HGNC:7329,mismatch repair cancer syndrome,MONDO:0031219,,No,,,,,
MUTYH,HGNC:7527,familial adenomatous polyposis 2,MONDO:0012041,AR,Yes,,,,,
MUTYH,HGNC:7527,familial ovarian cancer,MONDO:0016248,AR,NA,,,,,
MUTYH,HGNC:7527,hereditary breast carcinoma,MONDO:0016419,AR,NA,,,,,
MUTYH,HGNC:7527,colorectal cancer,MONDO:0005575,AD,NA,,,,,
MYBPC3,HGNC:7551,dilated cardiomyopathy,MONDO:0005021,AD,NA,,,,,
MYBPC3,HGNC:7551,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
MYBPC3,HGNC:7551,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
MYBPC3,HGNC:7551,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
MYBPC3,HGNC:7551,hypertrophic cardiomyopathy 4,MONDO:0007268,,Yes,,,,,
MYH11,HGNC:7569,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Yes,,,,,
MYH7,HGNC:7577,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
MYH7,HGNC:7577,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
MYH7,HGNC:7577,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
MYH7,HGNC:7577,MYH7-related skeletal myopathy,MONDO:0008050,AD,Pending,,,,,
MYH7,HGNC:7577,congenital heart disease,MONDO:0005453,AD,NA,,,,,
MYH7,HGNC:7577,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
MYH7,HGNC:7577,restrictive cardiomyopathy,MONDO:0005201,,Yes,,,,,
MYH7,HGNC:7577,cardiomyopathy,MONDO:0004994,,Yes,,,,,
MYH7,HGNC:7577,"congenital myopathy 7A, myosin storage, autosomal dominant",MONDO:0008409,,Pending,,,,,
MYH7,HGNC:7577,Ebstein anomaly,MONDO:0009144,,Pending,,,,,
MYL2,HGNC:7583,hypertrophic cardiomyopathy 10,MONDO:0012112,AD,Yes,,,,,
MYL2,HGNC:7583,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
MYL2,HGNC:7583,dilated cardiomyopathy,MONDO:0005021,AD,NA,,,,,
MYL2,HGNC:7583,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
MYL2,HGNC:7583,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
MYL3,HGNC:7584,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
MYL3,HGNC:7584,dilated cardiomyopathy,MONDO:0005021,AD,NA,,,,,
MYL3,HGNC:7584,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
MYL3,HGNC:7584,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
NF2,HGNC:7773,neurofibromatosis type 2,MONDO:0007039,AD,Yes,,,,,
OTC,HGNC:8512,ornithine carbamoyltransferase deficiency,MONDO:0010703,XL,Yes,,,,,
PALB2,HGNC:26144,Fanconi anemia complementation group N,MONDO:0012565,AR,No,,,,,
PALB2,HGNC:26144,hereditary nonpolyposis colon cancer,MONDO:0018630,AD,NA,,,,,
PALB2,HGNC:26144,hereditary breast carcinoma,MONDO:0016419,AD,Yes,,,,,
PALB2,HGNC:26144,familial ovarian cancer,MONDO:0016248,AD,Yes,,,,,
PCSK9,HGNC:20001,"hypercholesterolemia, autosomal dominant, 3",MONDO:0011369,AD,Yes,The mechanism of pathogenicity for SF reportable diseases is gain-of-function. LOF variants should not be reported as they are associated with low levels of LDL cholesterol.,,,,
PKP2,HGNC:9024,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,Yes,,,,,
PKP2,HGNC:9024,arrhythmogenic right ventricular dysplasia 9,MONDO:0012180,,Yes,,,,,
PKP2,HGNC:9024,Brugada syndrome 1,MONDO:0011001,AD,NA,,,,,
PKP2,HGNC:9024,dilated cardiomyopathy,MONDO:0005021,AD,NA,,,,,
PKP2,HGNC:9024,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,NA,,,,,
PMS2,HGNC:9122,mismatch repair cancer syndrome 1,MONDO:0010159,AR,No,,,,,
PMS2,HGNC:9122,Lynch syndrome,MONDO:0005835,AD,Yes,,,,,
PMS2,HGNC:9122,hereditary breast carcinoma,MONDO:0016419,AD,NA,,,,,
PMS2,HGNC:9122,Lynch syndrome 4,MONDO:0013699,,Yes,,,,,
PMS2,HGNC:9122,mismatch repair cancer syndrome,MONDO:0031219,,No,,,,,
PRKAG2,HGNC:9386,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
PRKAG2,HGNC:9386,PRKAG2-related cardiomyopathy,MONDO:0800484,AD,Yes,,,,,
PRKAG2,HGNC:9386,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
PTEN,HGNC:9588,PTEN hamartoma tumor syndrome,MONDO:0017623,AD,Yes,,,,,
PTEN,HGNC:9588,multiple exostoses with spastic tetraparesis,MONDO:0008020,,NA,,,,,
RB1,HGNC:9884,retinoblastoma,MONDO:0008380,AD,Yes,,,,,
RB1,HGNC:9884,hereditary retinoblastoma,MONDO:0018160,,Yes,,,,,
RBM20,HGNC:27424,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
RBM20,HGNC:27424,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,,,,,
RET,HGNC:9967,multiple endocrine neoplasia type 2A,MONDO:0008234,AD,Yes,The mechanism of pathogenicity for SF reportable diseases is gain-of-function. LOF variants should not be reported. ,,,,
RET,HGNC:9967,multiple endocrine neoplasia type 2B,MONDO:0008082,AD,Yes,The mechanism of pathogenicity for SF reportable diseases is gain-of-function. LOF variants should not be reported. ,,,,
RET,HGNC:9967,familial medullary thyroid carcinoma,MONDO:0007958,AD,Yes,The mechanism of pathogenicity for SF reportable diseases is gain-of-function. LOF variants should not be reported. ,,,,
RET,HGNC:9967,"Hirschsprung disease, susceptibility to, 1",MONDO:0007723,,No,The mechanism of pathogenicity for SF reportable diseases is gain-of-function. LOF variants should not be reported. ,,,,
RPE65,HGNC:10294,RPE65-related recessive retinopathy,MONDO:0100368,AR,Yes,,,,,
RPE65,HGNC:10294,RPE65-related dominant retinopathy,MONDO:0100452,AD,Pending,,,,,
RPE65,HGNC:10294,Leber congenital amaurosis 2,MONDO:0008765,,Yes,,,,,
RYR1,HGNC:10483,RYR1-related myopathy,MONDO:0100150,AR,No,RYR1 also causes a neuromuscular phenotype. Only P/LP variants associated with malignant hyperthermia should be reported as a secondary finding.,,,,
RYR1,HGNC:10483,"malignant hyperthermia, susceptibility to, 1",MONDO:0007783,AD,Yes,RYR1 also causes a neuromuscular phenotype. Only P/LP variants associated with malignant hyperthermia should be reported as a secondary finding.,,,,
RYR1,HGNC:10483,malignant hyperthermia of anesthesia,MONDO:0018493,,Yes,RYR1 also causes a neuromuscular phenotype. Only P/LP variants associated with malignant hyperthermia should be reported as a secondary finding.,,,,
RYR2,HGNC:10484,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,Yes,,,,,
RYR2,HGNC:10484,catecholaminergic polymorphic ventricular tachycardia 1,MONDO:0011484,,Yes,,,,,
RYR2,HGNC:10484,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,,,,,
RYR2,HGNC:10484,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
SCN5A,HGNC:10593,familial long QT syndrome,MONDO:0019171,AD,Yes,,,,,
SCN5A,HGNC:10593,Brugada syndrome,MONDO:0015263,AD,Yes,,,,,
SCN5A,HGNC:10593,Brugada syndrome 1,MONDO:0011001,,Yes,,,,,
SCN5A,HGNC:10593,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
SCN5A,HGNC:10593,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AD,NA,,,,,
SCN5A,HGNC:10593,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
SCN5A,HGNC:10593,short QT syndrome,MONDO:0000453,AD,NA,,,,,
SDHAF2,HGNC:26034,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
SDHB,HGNC:10681,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
SDHB,HGNC:10681,mitochondrial disease,MONDO:0044970,AR,No,,,,,
SDHC,HGNC:10682,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
SDHC,HGNC:10682,mitochondrial disease,MONDO:0044970,Other,NA,,,,,
SDHC,HGNC:10682,paragangliomas 3,MONDO:0011544,,Yes,,,,,
SDHD,HGNC:10683,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
SDHD,HGNC:10683,mitochondrial disease,MONDO:0044970,AR,NA,,,,,
SDHD,HGNC:10683,paragangliomas 1,MONDO:0008192,,Yes,,,,,
SMAD3,HGNC:6769,aneurysm-osteoarthritis syndrome,MONDO:0013426,AD,Pending,,,,,
SMAD3,HGNC:6769,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Yes,,,,,
SMAD3,HGNC:6769,Loeys-Dietz syndrome,MONDO:0018954,,Yes,,,,,
SMAD4,HGNC:6770,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MONDO:0008278,AD,Yes,"Variants in SMAD4 are linked to juvenile polyposis with hereditary hemorrhagic telangiectasia (JP/HHT) syndrome, juvenile intestinal polyposis syndrome (JPS), and Myhre syndrome. JP/HHT and JPS are due to heterozygous loss of function variants. Myhre syndrome is caused by one of four SMAD4 missense variants [c.1498A>G (p.Ile500Val); c.1499T>C (p.Ile500Thr); c.1500A>G (p.Ile500Met), and c.1486C>T (p.Arg496Cys)].",,,,
SMAD4,HGNC:6770,Myhre syndrome,MONDO:0007688,AD,No,"Variants in SMAD4 are linked to juvenile polyposis with hereditary hemorrhagic telangiectasia (JP/HHT) syndrome, juvenile intestinal polyposis syndrome (JPS), and Myhre syndrome. JP/HHT and JPS are due to heterozygous loss of function variants. Myhre syndrome is caused by one of four SMAD4 missense variants [c.1498A>G (p.Ile500Val); c.1499T>C (p.Ile500Thr); c.1500A>G (p.Ile500Met), and c.1486C>T (p.Arg496Cys)].",,,,
SMAD4,HGNC:6770,pulmonary arterial hypertension,MONDO:0015924,AD,NA,"Variants in SMAD4 are linked to juvenile polyposis with hereditary hemorrhagic telangiectasia (JP/HHT) syndrome, juvenile intestinal polyposis syndrome (JPS), and Myhre syndrome. JP/HHT and JPS are due to heterozygous loss of function variants. Myhre syndrome is caused by one of four SMAD4 missense variants [c.1498A>G (p.Ile500Val); c.1499T>C (p.Ile500Thr); c.1500A>G (p.Ile500Met), and c.1486C>T (p.Arg496Cys)].",,,,
SMAD4,HGNC:6770,juvenile polyposis syndrome,MONDO:0017380,,Yes,"Variants in SMAD4 are linked to juvenile polyposis with hereditary hemorrhagic telangiectasia (JP/HHT) syndrome, juvenile intestinal polyposis syndrome (JPS), and Myhre syndrome. JP/HHT and JPS are due to heterozygous loss of function variants. Myhre syndrome is caused by one of four SMAD4 missense variants [c.1498A>G (p.Ile500Val); c.1499T>C (p.Ile500Thr); c.1500A>G (p.Ile500Met), and c.1486C>T (p.Arg496Cys)].",,,,
STK11,HGNC:11389,familial ovarian cancer,MONDO:0016248,AD,NA,,,,,
STK11,HGNC:11389,Peutz-Jeghers syndrome,MONDO:0008280,AD,Yes,,,,,
TGFBR1,HGNC:11772,Loeys-Dietz syndrome,MONDO:0018954,AD,Yes,"Missense mutations in the intracellular kinase domain of TGFBR1 are known to cause Loeys-Dietz syndrome with unclear molecular mechanism which could include gain of function and dominant negative, whereas truncating variants or missense variants in the receptor domain of TGFBR1 cause multiple self-healing squamous epithelioma (MSSE; OMIM 132800) with loss of function mechanism.",,,,
TGFBR1,HGNC:11772,multiple self-healing squamous epithelioma,MONDO:0007566,AD,Pending,"Missense mutations in the intracellular kinase domain of TGFBR1 are known to cause Loeys-Dietz syndrome with unclear molecular mechanism which could include gain of function and dominant negative, whereas truncating variants or missense variants in the receptor domain of TGFBR1 cause multiple self-healing squamous epithelioma (MSSE; OMIM 132800) with loss of function mechanism.",,,,
TGFBR1,HGNC:11772,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Yes,"Missense mutations in the intracellular kinase domain of TGFBR1 are known to cause Loeys-Dietz syndrome with unclear molecular mechanism which could include gain of function and dominant negative, whereas truncating variants or missense variants in the receptor domain of TGFBR1 cause multiple self-healing squamous epithelioma (MSSE; OMIM 132800) with loss of function mechanism.",,,,
TGFBR2,HGNC:11773,familial thoracic aortic aneurysm and aortic dissection,MONDO:0019625,AD,Yes,,,,,
TGFBR2,HGNC:11773,Loeys-Dietz syndrome 2,MONDO:0012427,AD,Yes,,,,,
TGFBR2,HGNC:11773,Loeys-Dietz syndrome,MONDO:0018954,,Yes,,,,,
TMEM127,HGNC:26038,hereditary pheochromocytoma-paraganglioma,MONDO:0017366,AD,Yes,,,,,
TMEM43,HGNC:28472,arrhythmogenic right ventricular dysplasia 5,MONDO:0011459,AD,Yes,,,,,
TNNC1,HGNC:11943,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
TNNC1,HGNC:11943,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
TNNC1,HGNC:11943,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
TNNI3,HGNC:11947,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
TNNI3,HGNC:11947,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
TNNI3,HGNC:11947,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
TNNI3,HGNC:11947,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
TNNI3,HGNC:11947,"cardiomyopathy, familial restrictive, 1",MONDO:0007270,,Yes,,,,,
TNNT2,HGNC:11949,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
TNNT2,HGNC:11949,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
TNNT2,HGNC:11949,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
TNNT2,HGNC:11949,familial hypertrophic cardiomyopathy,MONDO:0024573,AD,Yes,,,,,
TP53,HGNC:11998,Li-Fraumeni syndrome,MONDO:0018875,AD,Yes,,,,,
TP53,HGNC:11998,Li-Fraumeni syndrome 1,MONDO:0007903,,Yes,,,,,
TPM1,HGNC:12010,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,,,,,
TPM1,HGNC:12010,dilated cardiomyopathy,MONDO:0005021,AD,Yes,,,,,
TPM1,HGNC:12010,hypertrophic cardiomyopathy,MONDO:0005045,AD,Yes,,,,,
TPM1,HGNC:12010,familial hypertrophic cardiomyopathy,MONDO:0024573,,Yes,,,,,
TRDN,HGNC:12261,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,AR,Yes,"The MANE Select transcript, NM_006073.4, which has 41 exons, is not the relevant transcript for cardiac disease reporting. Variants should only be reported in exons 1-8 of NM_001256021.1, the predominant transcript in cardiac tissue.",,,,
TRDN,HGNC:12261,catecholaminergic polymorphic ventricular tachycardia 5,MONDO:0014191,,Yes,"The MANE Select transcript, NM_006073.4, which has 41 exons, is not the relevant transcript for cardiac disease reporting. Variants should only be reported in exons 1-8 of NM_001256021.1, the predominant transcript in cardiac tissue.",,,,
TRDN,HGNC:12261,long QT syndrome,MONDO:0002442,AR,Yes,"The MANE Select transcript, NM_006073.4, which has 41 exons, is not the relevant transcript for cardiac disease reporting. Variants should only be reported in exons 1-8 of NM_001256021.1, the predominant transcript in cardiac tissue.",,,,
TSC1,HGNC:12362,tuberous sclerosis,MONDO:0001734,AD,Yes,,,,,
TSC1,HGNC:12362,tuberous sclerosis 1,MONDO:0008612,,Yes,,,,,
TSC2,HGNC:12363,tuberous sclerosis,MONDO:0001734,AD,Yes,,,,,
TSC2,HGNC:12363,tuberous sclerosis 2,MONDO:0013199,,Yes,,,,,
TTN,HGNC:12403,dilated cardiomyopathy,MONDO:0005021,AD,Yes,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,hypertrophic cardiomyopathy,MONDO:0005045,AD,NA,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,AD,NA,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,tibial muscular dystrophy,MONDO:0010870,AD,Pending,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,"myopathy, myofibrillar, 9, with early respiratory failure",MONDO:0011362,AD,Pending,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,TTN-related myopathy,MONDO:0100175,AR,No,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTN,HGNC:12403,dilated cardiomyopathy 1G,MONDO:0011400,,Yes,"We currently recommend that only frameshift and nonsense variants, and variants known to impact the splicing of TTN exons with high PSI (see references PMCID: PMC4560092; PMC5201198; http://cardiodb.org/titin) be evaluated for pathogenicity and returned as secondary findings if classified as P/LP.",,,,
TTR,HGNC:12405,obsolete hereditary ATTR amyloidosis,MONDO:0017132,AD,Yes,,,,,
TTR,HGNC:12405,familial amyloid neuropathy,MONDO:0007100,,Yes,,,,,
VHL,HGNC:12687,von Hippel-Lindau disease,MONDO:0008667,AD,Yes,,,,,
WT1,HGNC:12796,Wilms tumor 1,MONDO:0008679,AD,Yes,,,,,
WT1,HGNC:12796,Denys-Drash syndrome,MONDO:0008682,AD,Pending,,,,,